The Mumbai-headquartered firm, in a statement, said its subsidiary has received approval from US food and Drug Administration (USFDA) for its Doxorubicin HCl Liposome Injection.
"This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC," the company said.
Doxorubicin HCl liposome injection is used to treat patients with ovarian cancer that has progressed or recurred after platinum-based chemotherapy.
Wockhardt gets USFDA nod for anti-depressant tablets
Sesh: Pawan Kalyan is the USP of the film
Left's biggest USP may become its worst nightmare
Wockhardt gets USFDA nod for cardiac drug
IT industry pleased with results ahead of estimates